Amgen Apr 20, 2026 Pfizer, Amgen among 22 firms to expand in Hong Kong: SCMP (PFE:NYSE) - Seeking Alpha
FierceBiotech Apr 16, 2026 Pfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial
FierceBiotech Apr 6, 2026 With Sanofi and Pfizer deals, Novavax bets on ‘amplification strategy’ to drive vaccines engine
FierceBiotech Apr 1, 2026 Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story
FierceBiotech Apr 1, 2026 Oric chases Pfizer into phase 3 hailing prostate cancer edge, but investors send stock down
BioPharma Dive Mar 23, 2026 Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results
FierceBiotech Mar 23, 2026 Pfizer, Valneva blame low Lyme cases for phase 3 vaccine fail but still plan approval push
FierceBiotech Mar 12, 2026 Pfizer Ignite, designed to accelerate promising biotech therapies, fizzles out
BioPharma Dive Mar 6, 2026 Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs
Endpoints News Mar 6, 2026 Pfizer gets obesity drug approval in China shortly after buying local rights